Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biomarker Testing Market Forecast: What Value Will The Market Reach By 2030?
The biomarker testing market size has experienced rapid expansion in recent years. This market is set to expand from $19.75 billion in 2025 to $22.26 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth can be attributed to the increasing prevalence of chronic diseases, the expansion of clinical research activities, the rising adoption of molecular diagnostics, the growing demand for targeted therapies, and the availability of advanced testing platforms.
The biomarker testing market is projected to experience substantial expansion over the coming years. Its valuation is set to reach $35.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. This projected growth during the forecast period is primarily fueled by increased financial commitments to personalized medicine, the expanding application of biomarkers in pharmaceutical development, the broadening scope of testing for oncology and infectious diseases, a rising need for diagnostic methods that are less invasive, and breakthroughs in multi-omics technologies. Key developments expected during this timeframe encompass the greater acceptance of precision medicine diagnostics, the increasing utilization of companion diagnostics, the growing incorporation of AI into biomarker analysis, the widening use of liquid biopsy testing, and a stronger emphasis on detecting diseases at earlier stages.
Get A Free Sample Report With In-Depth Market Insights:
Biomarker Testing Market Growth Momentum: What Factors Are Shaping Demand?
The increasing incidence of cancer is projected to drive the expansion of the biomarker testing market. Cancer refers to a range of diseases characterized by the unchecked growth and spread of abnormal cells throughout the body. The escalating cancer burden is linked to lifestyle factors such as poor nutrition, smoking, lack of physical activity, and excessive consumption of alcohol. Biomarker testing enhances cancer detection by enabling the early and precise identification of markers specific to the disease, thereby improving diagnostic accuracy. Furthermore, it supports individualized treatment approaches, leading to improved patient outcomes and more effective healthcare management. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, approximately 165,000 new cancer cases were diagnosed in 2023, with projections indicating that roughly 204,000 cases will be diagnosed annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Consequently, the rising cancer burden is a significant factor propelling the growth of the biomarker testing market.
Biomarker Testing Market Segment Analysis Spotlighting Growth Areas
The biomarker testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments, Services
2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies
3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers
2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers
3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services
Biomarker Testing Market Trends Redefining Industry Growth
Major companies engaged in the biomarker testing market are focused on developing technologically advanced solutions, including immunohistochemistry (IHC) technology, to improve diagnostic accuracy, enable early disease detection, and support personalized treatment strategies. Immunohistochemistry (IHC) technology represents a laboratory method that utilizes antibodies to pinpoint specific proteins in tissue samples, aiding in the identification and visualization of biomarkers for disease diagnosis and research. For instance, in July 2023, Quest Diagnostics Incorporated, a US-based medical laboratories company, launched a new tissue-based prostate cancer biomarker test through its AmeriPath business to enhance diagnostic accuracy utilizing proprietary biomarkers EV1, EV2, and EV3. This test addresses a vital clinical need by assisting physicians in more precisely identifying and differentiating aggressive forms of prostate cancer, thereby improving grading consistency and guiding appropriate treatment strategies for patients.
Biomarker Testing Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc
View The Full Biomarker Testing Market Report:
Biomarker Testing Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









